Mirae Asset Global ETFs Holdings
IOVA icon

Mirae Asset Global ETFs Holdings’s Iovance Biotherapeutics IOVA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$657K Buy
188,914
+4,946
+3% +$15.8K ﹤0.01% 1737
2025
Q4 		$504K Buy
183,968
+39,052
+27% +$90.3K ﹤0.01% 1893
2025
Q3 		$316K Sell
144,916
-9,781
-6% -$23.1K ﹤0.01% 2084
2025
Q2 		$266K Sell
154,697
-28,094
-15% -$69.9K ﹤0.01% 2139
2025
Q1 		$613K Buy
182,791
+4,488
+3% +$23.1K ﹤0.01% 1756
2024
Q4 		$1.31M Buy
178,303
+13,987
+9% +$130K ﹤0.01% 1404
2024
Q3 		$1.55M Buy
164,316
+18,556
+13% +$176K ﹤0.01% 1290
2024
Q2 		$1.17M Buy
+145,760
New +$1.56M ﹤0.01% 1371

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return